Mode
Text Size
Log in / Sign up

Meta-analysis shows systemic heparinization reduces early patency loss in adult AVF or graft placement

Meta-analysis shows systemic heparinization reduces early patency loss in adult AVF or graft placeme…
Photo by Protais Benjamin MUGENZI / Unsplash
Key Takeaway
Consider systemic heparinization for early patency loss but weigh bleeding risk.

This meta-analysis examined the impact of systemic heparinization compared to standard care in adults undergoing arm arteriovenous fistula or graft placement. The pooled analysis included 1265 patients from the included studies. The primary outcome of interest was early patency loss, while secondary outcomes focused on bleeding complications. Follow-up duration was not reported for the individual studies within this synthesis.

The analysis found that systemic heparinization was associated with significantly reduced odds of early patency loss. The pooled odds ratio was 0.58 with a 95% confidence interval of 0.37 to 0.92. This reduction in patency loss was statistically significant with a p-value of 0.02.

Conversely, the use of systemic heparinization was associated with an increased risk of bleeding complications. The pooled odds ratio for bleeding was 4.24 with a 95% confidence interval of 1.13 to 15.9. This increase in bleeding risk was not statistically significant with a p-value of 0.13. The authors note that the absolute numbers for these events were not reported in the source data.

Practice relevance suggests that heparin may be considered a viable preventive strategy against early thrombosis. However, its use should be balanced against individual patient bleeding risk and surgical considerations. No specific funding sources or conflicts of interest were reported for this meta-analysis.

Study Details

Study typeMeta analysis
Sample sizen = 1,265
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: A significant proportion of arteriovenous fistulas (AVFs) and grafts for hemodialysis fail due to early thrombosis, necessitating reintervention. The role of systemic heparinization in improving perioperative patency remains uncertain. This meta-analysis aims to evaluate the efficacy and safety of perioperative systemic heparin on the patency of upper-limb vascular access creations (fistulas or grafts placement). METHODS: We searched PubMed, Embase, and Cochrane databases for randomized trials comparing heparinization versus standard care in adults undergoing arm AVF or graft placement. Data were pooled using a random-effects model to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity was assessed using I statistics. All statistical analyses were conducted using Review Manager 5.4. RESULTS: Six studies comprising 1,265 patients were included, of whom 731 (58%) underwent heparinization. Systemic heparinization significantly reduced the odds of early patency loss compared to standard care (OR: 0.58; 95% CI: 0.37-0.92; P = 0.02; I = 14%). However, heparin was associated with an increased risk of bleeding complications (OR: 4.24; 95% CI: 1.13-15.9; P = 0.13; I = 47%). CONCLUSION: Perioperative systemic heparinization significantly improves early patency rates for hemodialysis vascular access in adults undergoing arm fistulization or graft placement; however, there is a risk of increased bleeding events. Heparin may be considered a viable preventive strategy against early thrombosis, though its use should be balanced against individual patient bleeding risk and surgical considerations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.